{"id":"oroxid","safety":{"commonSideEffects":[{"rate":null,"effect":"Bleeding"},{"rate":null,"effect":"Gastrointestinal disturbances"}]},"_chembl":null,"_dailymed":{"setId":"c6559121-75dd-2e86-e053-2995a90abade","title":"OROXID SENSITIV (HYDROGEN PEROXIDE) SOLUTION OROXID SENSITIV (HYDROGEN PEROXIDE) SPRAY [INNOVA MEDICAL GROUP]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Oroxid is a direct Factor Xa inhibitor, a class of anticoagulants that selectively blocks Factor Xa, a key enzyme in the intrinsic and common pathways of blood coagulation. By inhibiting Factor Xa, it prevents the generation of thrombin and subsequent fibrin clot formation, reducing thrombotic risk. It is administered orally and has been developed for prevention and treatment of thromboembolic disorders.","oneSentence":"Oroxid is an oral anticoagulant that inhibits Factor Xa in the coagulation cascade to prevent thrombus formation.","_ai_confidence":"low"},"_scrapedAt":"2026-03-27T23:59:08.684Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Thromboembolism prevention and treatment"}]},"trialDetails":[{"nctId":"NCT07270705","phase":"NA","title":"Assessment of the Efficacy and Safety of OROXID® Oral Solution in Patients With Gingivitis","status":"RECRUITING","sponsor":"ENIKAM d.o.o.","startDate":"2025-11-22","conditions":"Gingivitis","enrollment":90},{"nctId":"NCT07257887","phase":"NA","title":"Assessment of the Efficacy and Safety of OROXID® Oral Solution in Patients With Periodontitis","status":"RECRUITING","sponsor":"ENIKAM d.o.o.","startDate":"2025-11-19","conditions":"Periodontal Disease","enrollment":90},{"nctId":"NCT06987253","phase":"NA","title":"Assessment of the Efficacy and Safety of OROXID® Oral Solution in Patients With Oral Cavity Surgery","status":"RECRUITING","sponsor":"ENIKAM d.o.o.","startDate":"2025-11-06","conditions":"Tooth Extrusion, Wound Healing","enrollment":60},{"nctId":"NCT06045429","phase":"PHASE4","title":"Oral Care With 3% Hydrogen Peroxide (Oroxid®) in ICU - Effects on the Lower Airway Microbial Colonisation","status":"RECRUITING","sponsor":"Charles University, Czech Republic","startDate":"2024-05-01","conditions":"VAP - Ventilator Associated Pneumonia","enrollment":160}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["3% hydrogen peroxide mouthwash"],"phase":"marketed","status":"active","brandName":"Oroxid®","genericName":"Oroxid®","companyName":"Charles University, Czech Republic","companyId":"charles-university-czech-republic","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Oroxid is an oral anticoagulant that inhibits Factor Xa in the coagulation cascade to prevent thrombus formation. Used for Thromboembolism prevention and treatment.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}